Petredis Investment Advisors’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.14M Buy
17,811
+4
+0% +$263 0.08% 95
2026
Q1
$1.27M Sell
17,807
-168
-0.9% -$13.2K 0.1% 89
2025
Q4
$1.47M Sell
17,975
-191
-1% -$14.9K 0.12% 87
2025
Q3
$1.36M Sell
18,166
-178
-1% -$13.3K 0.11% 90
2025
Q2
$1.36M Buy
18,344
+312
+2% +$21.7K 0.12% 89
2025
Q1
$1.46M Buy
18,032
+383
+2% +$32.9K 0.15% 84
2024
Q4
$1.38M Sell
17,649
-329
-2% -$28K 0.14% 81
2024
Q3
$1.69M Buy
17,978
+74
+0.4% +$6.21K 0.18% 83
2024
Q2
$1.4M Sell
17,904
-32
-0.2% -$2.61K 0.16% 85
2024
Q1
$1.63M Buy
17,936
+533
+3% +$44.3K 0.2% 83
2023
Q4
$1.35M Sell
17,403
-503
-3% -$35.2K 0.18% 85
2023
Q3
$1.22M Buy
17,906
+66
+0.4% +$4.8K 0.17% 85
2023
Q2
$1.45M Sell
17,840
-22
-0.1% -$1.76K 0.2% 86
2023
Q1
$1.47M Buy
+17,862
New +$1.28M 0.23% 82

Other funds holding GEHC

Petredis Investment Advisors's GEHC Position: Q2 2026 in Review

Petredis Investment Advisors increased its GE HealthCare (GEHC) stake by 0.02% in Q2 2026, buying an estimated $263 and bringing the position to 17,811 shares worth $1.14M. The position accounts for 0.08% of the portfolio, ranked #95.

Petredis Investment Advisors first reported a position in GEHC in Q1 2023 and has held it in 14 quarters since. The position peaked at $1.69M in Q3 2024. 1,223 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Petredis Investment Advisors held 17,811 shares of GE HealthCare worth $1.14M as of Q2 2026.
  • Petredis Investment Advisors bought 4 GE HealthCare shares in Q2 2026, an estimated $263.
  • GE HealthCare made up 0.08% of Petredis Investment Advisors's portfolio in Q2 2026, its #95 holding.
  • Petredis Investment Advisors first reported a position in GE HealthCare in Q1 2023 and has held it in 14 quarters since.
  • Petredis Investment Advisors's GE HealthCare position peaked at $1.69M in Q3 2024.
  • 1,223 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Petredis Investment Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.